These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of somatostatin in a case of severe hypoglycemia due to nesidioblastosis.
    Author: Roti E, Ghinelli C, Bandini P, Del Rossi C, Emanuele R, Robuschi G, Gnudi A.
    Journal: J Endocrinol Invest; 1981; 4(2):209-12. PubMed ID: 6115880.
    Abstract:
    The Authors have studied the effects of somatostatin (SRIF) treatment in an infant affected by hypoglycemia due to nesidioblastosis. During iv infusion with SRIF we observed a marked increase of blood glucose levels; concomitantly insulin secretion was almost completely suppressed. In contrast, during treatment with protamine zinc-somatostatin (PZ-SRIF), a long acting SRIF preparation, the blood glucose levels did not rise and insulin concentrations were inappropriately elevated. Therefore in this case the long term treatment of hypoglycemia due to nesidioblastosis with PZ-somatostatin was unfeasible.
    [Abstract] [Full Text] [Related] [New Search]